Radiotherapy Guided by New Imaging for Kidney Cancer
Tests newer imaging to guide radiotherapy for kidney cancer in adults.
Plain-language title generated from the registry record
Registry title: CBCT Guided Markerless SBRT for Renal Cell Cancer
Key facts
- Where
- Rotterdam, NetherlandsSee the site
Where in Netherlands
- Erasmus MCRotterdam, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Erasmus Medical Center
- Trial code
- NCT07402109
- Record updated
- 8 April 2026
- Original description
This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniquesRead full original descriptionShow less
Organ Sparing Marker-less CBCT-guided Stereotactic Adaptive Radiotherapy for Primary Non-metastasized Renal Tumors
This study aims to improve the treatment of kidney tumors using radiotherapy, by investigating whether kidney cancer can be more effectively irradiated with the help of new imaging techniques
Inclusion: Patients with histologically proven non-metastastic RCC or high suspicion of RCC based on imaging without histological evidence; No metastatic lesions; Patients must be 18 years or older; Ability to understand the requirements of the study and to give written informed consent, as determined by the treating physician; Written informed consent.
Exclusion: Previous high-dose radiotherapy in the region of the kidney.